A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease
Crossref DOI link: https://doi.org/10.1007/s10787-019-00595-4
Published Online: 2019-05-03
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bjarnason, Ingvar http://orcid.org/0000-0002-5520-492X
Sission, Guy
Hayee, Bu’Hussaine
Funding for this research was provided by:
Symprove Ltd (King's College Hospital)
Text and Data Mining valid from 2019-05-03
Article History
Received: 20 January 2019
Accepted: 3 April 2019
First Online: 3 May 2019